Xenetic Biosciences, Inc.
XBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,842 | $6,045 | $4,025 | $6,153 |
| - Cash | $4,122 | $4,780 | $5,164 | $6,166 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $721 | $1,265 | -$1,139 | -$12 |
| Revenue | $1,027 | $590 | $593 | $649 |
| % Growth | 74.1% | -0.6% | -8.6% | – |
| Gross Profit | $1,027 | $590 | $593 | $649 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$523 | -$724 | -$942 | -$1,099 |
| % Margin | -50.9% | -122.8% | -158.9% | -169.4% |
| Net Income | -$510 | -$689 | -$903 | -$1,055 |
| % Margin | -49.7% | -116.7% | -152.2% | -162.5% |
| EPS Diluted | -0.33 | -0.45 | -0.59 | -0.68 |
| % Growth | 26.7% | 23.7% | 13.2% | – |
| Operating Cash Flow | -$658 | -$384 | -$1,002 | -$674 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$658 | -$384 | -$1,002 | -$674 |